Betamethasone cream for corticosteroid-responsive skin conditions

Betamethasone dipropionate cream 0.05% is a potent topical corticosteroid used to relieve inflammation and itching associated with steroid-responsive skin disorders. It works by reducing inflammatory and immune responses in the skin.

This medication is indicated for the relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in patients requiring topical treatment.

betamethasone dipropionate 0.5 mg per gram

Betamethasone is a synthetic corticosteroid with strong glucocorticoid effects that reduce inflammation and suppress immune reactions in the skin. Its anti-inflammatory, anti-itch (anti-pruritic), and blood vessel-constricting actions help ease symptoms of skin conditions.

Adults and children:

• Apply a thin layer of the cream once daily to the affected skin area. In some cases, twice daily application may be needed.
• Do not use occlusive dressings (such as tight bandaging) on treated areas when using this cream.
• If a skin infection develops, topical corticosteroid treatment should be stopped and appropriate antimicrobial therapy started.

Contraindicated in patients with known hypersensitivity to any component of the preparation.

Serious risks and monitoring:

• Systemic absorption can lead to hypothalamic-pituitary-adrenal (HPA) axis suppression, Cushing's syndrome, hyperglycemia, and glucosuria, especially with potent steroids over large areas, prolonged use, or occlusive dressings.
• Patients using large doses on extensive skin areas should be evaluated periodically for HPA axis suppression using urinary free cortisol and ACTH stimulation tests.
• If suppression is detected, reduce dosage or switch to a less potent corticosteroid.
• Children are more susceptible to systemic side effects due to a higher skin surface area-to-weight ratio; use lowest effective amounts and duration.
• Avoid use around eyes; not for ophthalmic use.
• If skin irritation or infection occurs, discontinue use and treat appropriately.

Local side effects reported infrequently include burning, itching, irritation, dryness, folliculitis, increased hair growth, acne-like eruptions, skin lightening (hypopigmentation), perioral dermatitis, allergic contact dermatitis, skin maceration, secondary infections, skin thinning (atrophy), stretch marks (striae), and miliaria.

Systemic absorption may cause reversible adrenal suppression and signs of Cushing's syndrome.

Not explicitly detailed in the label.

Pregnancy: Topical corticosteroids have shown teratogenic effects in animal studies at systemic doses. There are no adequate controlled studies in pregnant women. Use only if the potential benefit justifies the risk. Avoid extensive, prolonged, or large area use during pregnancy.

Lactation: It is unknown if topical corticosteroids are secreted in breast milk in amounts that affect the infant. Exercise caution when applying to nursing mothers.

Excessive topical use may lead to systemic corticosteroid effects such as HPA axis suppression. Discontinue use and manage symptoms accordingly.

Store at 25°C (77°F); excursions permitted between 15° and 30°C (59° and 86°F). Protect from light and freezing.